C’Dots, silica-encased nanoparticles developed in the lab of engineering professor Ulrich Wiesner, have just begun their first therapeutic human clinical trial. They’re being further developed by Elucida Oncology Inc., a company co-founded by Wiesner.
Pound for pound, the brain consumes vastly more energy than other organs. Now, researchers at Weill Cornell Medicine have found that the process of packaging neurotransmitters may be responsible for this energy drain.
Vanessa Bohns, a social psychologist and professor of organizational behavior at the ILR School, says there are ways – starting with intentional rest and recovery – to recalibrate after nearly two years of a pandemic-induced, always-on work mindset.
A gene mutation linked to Alzheimer’s disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study by scientists at Weill Cornell Medicine.
Moonshadow, a new variety of grape tomato, is a high-flavor, traditionally bred tomato derived from crosses with heirloom varieties. It’s aimed at organic growers, small farms and home gardeners.
For physician and epidemiologist Dr. Jay Varma, the COVID-19 pandemic underscores not only the importance of public health, but also the powerful and pressing role of governments, academic medical centers and other organizations to work together on emerging health threats.
A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis and other brain inflammation-related conditions, according to a new study by Weill Cornell Medicine researchers.
Examples of how community-engaged learning projects can address community needs were showcased during a virtual forum on Nov. 17. The projects demonstrate the College of Human Ecology’s Engaged College Initiative, a partnership between the college and the David M. Einhorn Center for Community Engagement that supports learning with a community engagement component.
